A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
2021
Journal of Hepatocellular Carcinoma
Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and clinical aspects of both existing and emerging percutaneous treatment options for HCC.
doi:10.2147/jhc.s268300
pmid:34589446
pmcid:PMC8476177
fatcat:ngwqo4mvvbewpeiwxvhyg3irmi